Showing results (401-410 of 1,372) with videos related to
Sort By:
Pageof 138
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 6, 2017
Qualitative and quantitative assessment of self-reported cognitive difficulties in nondemented elders: Association with medical help seeking, cognitive deficits, and β-amyloid imagingRenaud La Joie, Audrey Perrotin, Stéphanie Egret, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 29, 2017
A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission tomography imagingYi Mo, Julie Stromswold, Kimberly Wilson, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 9, 2016
The ratio of phosphatidylcholines to lysophosphatidylcholines in plasma differentiates healthy controls from patients with Alzheimer's disease and mild cognitive impairmentKristaps Klavins, Therese Koal, Guido Dallmann, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 3, 2016
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizesPhilip S J Weston, Ross W Paterson, Marc Modat, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 18, 2020
Theoretical frameworks and approaches used within the Reserve, Resilience and Protective Factors professional interest area of the Alzheimer's Association International Society to Advance Alzheimer's Research and TreatmentDavid Bartrés-Faz, Eider Arenaza-Urquijo, Michael Ewers, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 3, 2020
Sex differences in memory clinic patients with possible vascular cognitive impairmentLieza G Exalto, Jooske M F Boomsma, Rosha Babapour Mofrad, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 9, 2019
Practical algorithms for amyloid β probability in subjective or mild cognitive impairmentNancy Maserejian, Shijia Bian, Wenting Wang, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 8, 2020
Longitudinal trajectories of amyloid deposition, cortical thickness, and tau in Down syndrome: A deep-phenotyping case reportElijah Mak, Anastasia Bickerton, Concepcion Padilla, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 24, 2019
Serum levels of proteins involved in amyloid-β clearance are related to cognitive decline and neuroimaging changes in mild cognitive impairmentShan Liu, Hideaki Suzuki, Hitomi Ito, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 2, 2019
Harmonization of neuroimaging biomarkers for neurodegenerative diseases: A survey in the imaging community of perceived barriers and suggested actionsJorge Jovicich, Frederik Barkhof, Claudio Babiloni, et al.Pageof 138